Evaluation of MEK inhibitor chemosensitivity in human tumor explants using the Mosaic Blue Assay and relationship to biomarkers by immunohistochemistry

Category Primary study
JournalMolecular Cancer Therapeutics
Year 2013
This article has no abstract
Epistemonikos ID: d2ca5bc9f7509006753169d04702118914ceb48f
First added on: Feb 05, 2025